Table 2.
Number of deaths from suicide, accidents, and cardiovascular disorders, and associated standardized mortality ratios (SMRs) among individuals who ever used beta-blockers, calcium channel blockers or angiotensin converting enzyme inhibitors, 1989–1995.
| β-adrenoceptor blockers | Calcium channel blockers | ACE-inhibitors | ||||
|---|---|---|---|---|---|---|
| Variable | Obs | SMR (95% CI) | Obs | SMR (95% CI) | Obs | SMR (95% CI) |
| Cause of death | ||||||
| All causes | 3662 | 1.24 (1.20, 1.29) | 4985 | 1.50 (1.46, 1.54) | 2871 | 2.02 (1.95, 2.09) |
| Suicide | 53 | 1.6 (1.2, 2.1) | 33 | 1.2 (0.8, 1.7) | 18 | 1.2 (0.7, 1.8) |
| Accidents | 116 | 1.0 (0.9, 1.3) | 117 | 0.9 (0.8, 1.1) | 64 | 1.2 (1.0, 1.6) |
| Cardiovascular disorders | 2013 | 1.56 (1.49, 1.63) | 3078 | 2.02 (1.95, 2.09) | 1851 | 2.99 (2.86, 3.13) |
| Hypertension | 69 | 4.1 (3.2, 5.2) | 69 | 3.7 (2.9, 4.7) | 49 | 6.0 (4.4, 7.9) |
| Ischaemic heart disease | 1280 | 1.7 (1.6, 1.8) | 2158 | 2.5 (2.4, 2.6) | 1262 | 3.5 (3.3, 3.7) |
| Cerebrovascular diseases | 368 | 1.3 (1.2, 1.4) | 434 | 1.3 (1.2, 1.4) | 215 | 1.6 (1.4, 1.8) |
| Other cardiovascular disorders | 296 | 1.2 (1.1, 1.4) | 417 | 1.4 (1.3, 1.6) | 325 | 2.8 (2.5, 3.1) |
| Other causes | ||||||
| Liver cirrhosis, cholelithiasis and cholecystitis | 56 | 1.8 (1.4, 2.3) | 22 | 0.8 (0.5, 1.1) | 20 | 1.3 (0.8, 2.0) |
| Bronchitis, emphysema and asthma | 59 | 0.5 (0.4, 0.6) | 189 | 1.3 (1.1, 1.5) | 111 | 1.7 (1.4, 2.0) |
| Diabetes | 60 | 1.4 (1.0, 1.8) | 105 | 2.2 (1.8, 2.7) | 104 | 5.0 (4.1, 6.1) |